Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03876457 · ClinicalTrials.gov registry record · NA
SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
A NA study, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 352
- Enrollment target
NCT03876457 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 352 participants.
The verdict
NCT03876457, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 352 participants
- Enrollment target
Study Summary
SELECT 2 evaluates the efficacy and safety of endovascular thrombectomy compared to medical management alone in acute ischemic stroke patients due to a large vessel occlusion in the distal ICA and MCA M1 who have large core on either CT (ASPECTS: 3-5) or advanced perfusion imaging (\[rCBF\<30%\] on CTP or \[ADC\<620\] on MRI: ≥50cc) or both and are treated within 0-24 hours from last known well.
Interventions
- OTHER Medical Management
- DEVICE Endovascular Thrombectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2019-10-11 |
| Est. Completion | 2023-11-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03876457
The ClinicalTrials.gov registry entry for NCT03876457 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medical Management is the first listed.
NCT03876457 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03876457 about?
NCT03876457 is a clinical study titled "SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke". SELECT 2 evaluates the efficacy and safety of endovascular thrombectomy compared to medical management alone in acute ischemic stroke patients due to a large vessel occlusion in the distal ICA and MCA M1 who have large core on either CT (ASPECTS: 3-5) or advanced perfusion imaging (\[rCBF\<30%\] on ...
What is the current status of trial NCT03876457?
This trial is currently completed. It is a NA study. The enrollment target is 352 participants. The study started on 2019-10-11. Estimated completion is 2023-11-16.
What interventions are being tested in trial NCT03876457?
The interventions under investigation include: Medical Management (OTHER), Endovascular Thrombectomy (DEVICE).
Who is sponsoring clinical trial NCT03876457?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.